The future of influenza vaccines

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b4014 (Published 6 October 2009)
Cite this as: BMJ 2009;339:b4014

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Menno D de Jong, professor of clinical virology1,
  2. Rogier W Sanders, assistant professor of microbiology and immunology2
  1. 1Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, 1105 AZ Amsterdam, Netherlands
  2. 2Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA
  1. m.d.dejong{at}amc.nl

    Innovative techniques promise to be proactive rather than reactive

    The linked case-control study by Garcia-Garcia and colleagues (doi:10.1136/bmj.b3928) shows that, contrary to earlier speculation, some level of cross protection against the new influenza A/H1N1 virus may be provided by the 2008-9 seasonal flu vaccine.1 In a group of 60 confirmed infected and 180 uninfected controls, uninfected people were significantly more likely to have received the seasonal flu vaccine (29% v 13%). Turning the data around, of the 179 unvaccinated people in the study, 52 (29%) became infected with pandemic H1N1 whereas eight of 61 (13%) vaccinated people became infected. Furthermore, all of these eight people survived, whereas 18 of the 52 unvaccinated people who were infected died. Despite the study’s limitations, the data suggest that vaccination with the seasonal flu vaccine confers some protection against pandemic H1N1 virus infection and severe disease from this infection.

    Although these observations agree with recently reported low rates of seroconversion to new H1N1 specific antibodies after seasonal vaccination in adults,2 the authors emphasise that their observations do not …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL